WHO ICTRP trial
Serum fibrinogen and fibrin degradation products (FDP) changes in hypothermia…
IRCT20180930041189N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180930041189N1 |
|---|---|
| Public title | Serum fibrinogen and fibrin degradation products (FDP) changes in hypothermia and normothermia in patients undergoing bypass |
| Scientific title | Assessing serum fibrinogen and fibrin degradation products (FDP) changes in hypothermia and normothermia in patients undergoing cardiopulmonary bypass |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | coronary heart disease. Atherosclerotic heart disease of native coronary artery |
| Interventions | Intervention 1: Intervention group: hyporthermic group: In this group, the temperature of the body was reduced untile 30- 34.9 ° C by a heater-cooler and a blanket (temperature changer). Intervention 2: Control group: normothermic group… |
| Registration date | Feb 10, 2019 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: